BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 17995990)

  • 1. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA; Costa G; Bond G; Abu-Elmagd KM
    Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in tardive dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
    Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
    Bona JR
    J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening tardive dyskinesia caused by metoclopramide.
    Samie MR; Dannenhoffer MA; Rozek S
    Mov Disord; 1987; 2(2):125-9. PubMed ID: 3504264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of postoperative nausea and vomiting in ENT--tardive dyskinesia as an adverse effect of metoclopramid--a case report].
    Tesche S; Henckell C; Metternich FU
    Laryngorhinootologie; 2006 Nov; 85(11):824-6. PubMed ID: 16586284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
    Chen PH; Liu HC
    J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Parikh MD; Rathi LG; Ghandi MH; Parikh RM; Thatte S; Bharadwaj J
    J Clin Psychopharmacol; 1982 Dec; 2(6):376-9. PubMed ID: 7174860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoclopramide-induced tardive dyskinesia in an infant.
    Mejia NI; Jankovic J
    Mov Disord; 2005 Jan; 20(1):86-9. PubMed ID: 15390048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
    Lyons KE; Pahwa R
    Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute chorea associated with metoclopramide use.
    Dubow JS; Leikin J; Rezak M
    Am J Ther; 2006; 13(6):543-4. PubMed ID: 17122536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: metoclopramide and tardive dyskinesia.
    Rao AS; Camilleri M
    Aliment Pharmacol Ther; 2010 Jan; 31(1):11-9. PubMed ID: 19886950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia.
    Alemdar M; Iseri P; Selekler M; Komsuoğlu SS
    Clin Neuropharmacol; 2007; 30(4):241-4. PubMed ID: 17762321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biopsychosocial approach to improving quality of life in tardive dystonia.
    Buscombe C; Alusi SH; Kahn DA
    J Psychiatr Pract; 2010 Sep; 16(5):350-7. PubMed ID: 20859113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.